Eplerenone: a selective aldosterone receptor antagonist for patients with heart failure (Q35980228)

11 August 2017

1 reference

title

Eplerenone: a selective aldosterone receptor antagonist for patients with heart failure (English)

1 reference

11 August 2017

Brian J Barnes

1

1 reference

PubMed ID

15590870

11 August 2017

Patricia A Howard

series ordinal

2

1 reference

PubMed ID

15590870

11 August 2017

language of work or name

English

0 references

publication date

8 December 2004

1 reference

Annals of Pharmacotherapy

11 August 2017

1 reference

11 August 2017

39

1 reference

11 August 2017

68-76

1 reference

11 August 2017

1

1 reference

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

11 August 2017

1 reference

Eplerenone--a novel selective aldosterone blocker

21 January 2018

1 reference

Aldosterone in congestive heart failure

21 January 2018

1 reference

RISE IN PLASMA CONCENTRATION OF ALDOSTERONE DURING LONG-TERM ANGIOTENSIN II SUPPRESSION

21 January 2018

1 reference

Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators.

21 January 2018

1 reference

Pathophysiological effects of aldosterone in cardiovascular tissues

21 January 2018

1 reference

Aldosterone antagonists in the treatment of hypertension and target organ damage

21 January 2018

1 reference

New biology of aldosterone, and experimental studies on the selective aldosterone blocker eplerenone

21 January 2018

1 reference

Mineralocorticoid receptor antagonists: The evolution of utility and pharmacology

21 January 2018

1 reference

Rationale for the use of aldosterone antagonists in congestive heart failure

21 January 2018

1 reference

Aldosterone as a target in congestive heart failure

21 January 2018

1 reference

Spironolactone improves angiotensin-induced vascular changes and oxidative stress

21 January 2018

1 reference

The renin-angiotensin-aldosterone system excites hypothalamic paraventricular nucleus neurons in heart failure

21 January 2018

1 reference

Aldosterone blockade in patients with systolic left ventricular dysfunction

21 January 2018

1 reference

Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure

21 January 2018

1 reference

Effects of long-term monotherapy with eplerenone, a novel aldosterone blocker, on progression of left ventricular dysfunction and remodeling in dogs with heart failure

21 January 2018

1 reference

Long-term, dose-dependent effects of spironolactone on left ventricular function and exercise tolerance in patients with chronic heart failure

21 January 2018

1 reference

Pharmacokinetics of spironolactone in man

21 January 2018

1 reference

Influence of food on the bioavailability of spironolactone

21 January 2018

1 reference

Spironolactone metabolism: steady-state serum levels of the sulfur-containing metabolites

21 January 2018

1 reference

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

21 January 2018

1 reference

Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study

21 January 2018

1 reference

Economic evaluation of the randomized aldactone evaluation study (RALES): treatment of patients with severe heart failure

21 January 2018

1 reference

Expanding the outcomes in clinical trials of heart failure: the quality of life and economic components of EPHESUS (EPlerenone's neuroHormonal Efficacy and SUrvival Study).

21 January 2018

1 reference

ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1E306

1 reference

11 August 2017

1 reference

PubMed ID

15590870